FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3149883437> ?p ?o ?g. }

• W3149883437 endingPage "631" @default.
• W3149883437 startingPage "621" @default.
• W3149883437 abstract "This study is a meta-analysis of randomized controlled trials involving first-line studies in which immune checkpoint inhibitors were added to chemotherapy and were compared with chemotherapy alone. The primary end point was overall survival (OS). The analyses used random-effects models and the Grading of Recommendations Assessment, Development, and Evaluation system to rate the quality of the evidence. Nine articles were included for qualitative and quantitative synthesis. A meta-analysis of the nine randomized trials showed a significant benefit in terms of OS (hazard ratio: 0.75 [95% CI: 0.66-0.85]; p < 0.01). Only programmed death ligand-1 positive-high cancers derive a significant OS benefit. In this meta-analysis, there is moderate evidence that the addition of immune checkpoint inhibitors to chemotherapy may improve both OS compared with chemotherapy alone.Lay abstract We provide a meta-analysis of randomized controlled trials in first-line studies where immune checkpoint inhibitors were added to chemotherapy (CT) and were compared with CT alone. Nine articles were included for qualitative and quantitative synthesis. A meta-analysis of the nine randomized trials indicated a significant benefit in terms of overall survival (OS; hazard ratio: 0.75 [95% CI: 0.66–0.85]; p < 0.01). Only programmed death ligand-1 positive-high cancers were observed to receive a significant OS benefit. In this meta-analysis, there is moderate evidence that the addition of immune checkpoint inhibitors to CT may improve OS as compared with CT alone." @default.
• W3149883437 created "2021-04-13" @default.
• W3149883437 creator A5009884142 @default.
• W3149883437 creator A5011289747 @default.
• W3149883437 creator A5012305930 @default.
• W3149883437 creator A5027018556 @default.
• W3149883437 creator A5032833091 @default.
• W3149883437 creator A5037756908 @default.
• W3149883437 creator A5056305832 @default.
• W3149883437 creator A5058439511 @default.
• W3149883437 creator A5076402959 @default.
• W3149883437 creator A5076806627 @default.
• W3149883437 creator A5091509029 @default.
• W3149883437 date "2021-05-01" @default.
• W3149883437 modified "2023-09-30" @default.
• W3149883437 title "Immune checkpoint inhibitors and chemotherapy in first-line NSCLC: a meta-analysis" @default.
• W3149883437 cites W1598602811 @default.
• W3149883437 cites W1994993231 @default.
• W3149883437 cites W2047902191 @default.
• W3149883437 cites W2098414192 @default.
• W3149883437 cites W2121080857 @default.
• W3149883437 cites W2419443098 @default.
• W3149883437 cites W2480201404 @default.
• W3149883437 cites W2527905628 @default.
• W3149883437 cites W2607272476 @default.
• W3149883437 cites W2745126191 @default.
• W3149883437 cites W2753529762 @default.
• W3149883437 cites W2804772768 @default.
• W3149883437 cites W2805354595 @default.
• W3149883437 cites W2888059202 @default.
• W3149883437 cites W2892640821 @default.
• W3149883437 cites W2893321040 @default.
• W3149883437 cites W2898352237 @default.
• W3149883437 cites W2903147538 @default.
• W3149883437 cites W2907028960 @default.
• W3149883437 cites W2946166987 @default.
• W3149883437 cites W2946386783 @default.
• W3149883437 cites W2946950110 @default.
• W3149883437 cites W2947926596 @default.
• W3149883437 cites W2955632382 @default.
• W3149883437 cites W2969539132 @default.
• W3149883437 cites W2998945317 @default.
• W3149883437 cites W3009099064 @default.
• W3149883437 cites W3017322331 @default.
• W3149883437 cites W4210992155 @default.
• W3149883437 cites W4242460399 @default.
• W3149883437 cites W4294215472 @default.
• W3149883437 doi "https://doi.org/10.2217/imt-2020-0224" @default.
• W3149883437 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33775103" @default.
• W3149883437 hasPublicationYear "2021" @default.
• W3149883437 type Work @default.
• W3149883437 sameAs 3149883437 @default.
• W3149883437 citedByCount "35" @default.
• W3149883437 countsByYear W31498834372021 @default.
• W3149883437 countsByYear W31498834372022 @default.
• W3149883437 countsByYear W31498834372023 @default.
• W3149883437 crossrefType "journal-article" @default.
• W3149883437 hasAuthorship W3149883437A5009884142 @default.
• W3149883437 hasAuthorship W3149883437A5011289747 @default.
• W3149883437 hasAuthorship W3149883437A5012305930 @default.
• W3149883437 hasAuthorship W3149883437A5027018556 @default.
• W3149883437 hasAuthorship W3149883437A5032833091 @default.
• W3149883437 hasAuthorship W3149883437A5037756908 @default.
• W3149883437 hasAuthorship W3149883437A5056305832 @default.
• W3149883437 hasAuthorship W3149883437A5058439511 @default.
• W3149883437 hasAuthorship W3149883437A5076402959 @default.
• W3149883437 hasAuthorship W3149883437A5076806627 @default.
• W3149883437 hasAuthorship W3149883437A5091509029 @default.
• W3149883437 hasConcept C121608353 @default.
• W3149883437 hasConcept C126322002 @default.
• W3149883437 hasConcept C143998085 @default.
• W3149883437 hasConcept C168563851 @default.
• W3149883437 hasConcept C203092338 @default.
• W3149883437 hasConcept C207103383 @default.
• W3149883437 hasConcept C2776694085 @default.
• W3149883437 hasConcept C2777701055 @default.
• W3149883437 hasConcept C2780851360 @default.
• W3149883437 hasConcept C44249647 @default.
• W3149883437 hasConcept C71924100 @default.
• W3149883437 hasConcept C95190672 @default.
• W3149883437 hasConceptScore W3149883437C121608353 @default.
• W3149883437 hasConceptScore W3149883437C126322002 @default.
• W3149883437 hasConceptScore W3149883437C143998085 @default.
• W3149883437 hasConceptScore W3149883437C168563851 @default.
• W3149883437 hasConceptScore W3149883437C203092338 @default.
• W3149883437 hasConceptScore W3149883437C207103383 @default.
• W3149883437 hasConceptScore W3149883437C2776694085 @default.
• W3149883437 hasConceptScore W3149883437C2777701055 @default.
• W3149883437 hasConceptScore W3149883437C2780851360 @default.
• W3149883437 hasConceptScore W3149883437C44249647 @default.
• W3149883437 hasConceptScore W3149883437C71924100 @default.
• W3149883437 hasConceptScore W3149883437C95190672 @default.
• W3149883437 hasIssue "7" @default.
• W3149883437 hasLocation W31498834371 @default.
• W3149883437 hasLocation W31498834372 @default.
• W3149883437 hasOpenAccess W3149883437 @default.
• W3149883437 hasPrimaryLocation W31498834371 @default.
• W3149883437 hasRelatedWork W1900595920 @default.

• next